'The Facts'

The 2024-25 Budget is fast approaching. We discuss what to look for, where to exercise caution, and what to ignore. More examples of where informing is confused with consulting leading to the problematic implementation of reform.

"Nuclear medicines, like radioligand therapy, could be transformative for cancer care in Australia. Establishing clear pathways for market access and a thriving nuclear medicine industry will be key to enabling Australian patients to access these new treatment options," said Novartis country president Matt Zeller.

The second issues paper released by the Albanese Government's scope of practice review has proposed the creation of another advisory committee.

Mark Butler's words should reverberate with the HTA review's reference committee as they prepare the final report. How will their recommendations address his public criticism of the 'clunky' and death-causing system?

The tense appearance of supermarket executives at Tuesday's Senate Select Committee on Supermarket Prices public hearing revealed a serious inconsistency regarding political opinions on the use of...

AbbVie vice president and general manager Nathalie McNeil said, “I’m thrilled to welcome Ally to the AbbVie ANZ team. Her leadership, strategic agility, people orientation and drive for always raising the bar is the perfect fit for the next chapter of our organisation.”

“The decision to step down from my role at Sanofi is not one I came to lightly. Over 28 years this organisation and the teams I have had the privilege to lead have become an enormous part of my life,” said Karen Hood.

One of Australia's most senior business leaders has told a Senate inquiry that he was surprised at the magnitude of Chemist Warehouse Group's revenue when it was revealed late last year.

One of Australia's longest-serving health sector leaders and well-known lobbyists is stepping down from the role they have held for almost 25 years.

“Boehringer has had a successful year as one of the leading research investors in the industry. Our impressive pipeline is coming together nicely, with many contributions from clinical trial sites in Australia and New Zealand," said Dirk Otto, the general manager of Boehringer Ingelheim Australia and New Zealand.

The Australian Manufacturing Technology Institute Limited has appointed Lorraine Maxwell (Chiroiu), a former AusBiotech leader, as its new CEO.

The Albanese Government hopes to attract the life sciences sector to Australia with a new $1.5 billion co-investment plan.